Mesa Laboratories (NASDAQ:MLAB – Get Free Report) was upgraded by equities research analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a research report issued on Thursday, Briefing.com reports. The brokerage currently has a $125.00 price target on the medical instruments supplier’s stock, up from their previous price target of $100.00. […]
Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) SVP Brian David Archbold sold 1,500 shares of the firm’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $112.36, for a total value of $168,540.00. Following the completion of the sale, the senior vice president now […]